Pharma News

The FDA has granted a fast track designation to the CAR T-cell therapy ADI-001 for the treatment of patients with relapsed/refractory B-cell non-Hodgkin lymphoma. ...

AbbVie has terminated its collaboration agreement with BioArctic in the development of alpha-synuclein antibodies for Parkinson's disease and other movement disorders. ...

Analyses are shared at the American Association for Cancer Research Annual Meeting 2022 in New Orleans, Louisiana.

The European Commission has approved Astellas Pharma’s and Seagen’s antibody drug conjugate, Padcev (enfortumab vedotin), for the treatment of adults with locally advanced or metastatic urothel...

The FDA has approved Amneal Pharmaceuticals’ Alymsys (bevacizumab-maly) as a biosimilar of Roche’s blockbuster cancer drug Avastin.

BioXcel Therapeutics, Inc. (BTAI) shares are gaining more than 7 percent on Tuesday morning trade after the company announced strategic financing agreements with Oaktree and Qatar Investment Author...

US biotech TG Therapeutics (Nasdaq: TGTX) saw its shares plunge almost 32% to $6.03, after it announced the voluntary withdrawal of the pending Biologics License Application (BLA)/supplemental New ...

Two strains of the bacterium causing tuberculosis have only minor genetic differences but attack the lungs in completely different fashion, according to Rutgers researchers. ...

Shares of Cassava Sciences plunged Tuesday in premarket trading after multiple Alzheimer’s researchers raised new concerns about the company’s experimental Alzheimer’s treatment, simufilam. ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended Merck Serono’s Tepmetko (tepotinib) for National Health Service (NHS) use in the treatment of certain adult pa...

The House Committee on Oversight and Reform has put out a staff report that calls out consulting firm McKinsey for simultaneously providing its services to pharmaceutical companies — including P...

Merck, known as MSD outside the United States and Canada, announced today that V116, the company’s investigational 21-valent pneumococcal conjugate vaccine, has received Breakthrough Therapy Des...